Clinical Trial Update: Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial of copanlisib in combination with gemcitabine and cisplatin for advanced cholangiocarcinoma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Carcinoma
• Cholangiocarcinoma
• Gall Bladder Carcinoma
• Gastrointestinal Tumor

Drugs mentioned

• CISPLATIN (cisplatin)
• Copanlisib (copanlisib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Biliary Carcinoma, Gall Bladder Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-11-02